Hikma Pharmaceuticals Dividend
Hikma Pharmaceuticals Dividend history 20 years & estimates 2026 to 2028
Dividend Analysis of the Hikma Pharmaceuticals Stock
| Current dividend yield | 6.0 % |
| Dividendenrendite 5 Jahre | 9.75 % |
| Dividend Yield 10Y | 1.64 % |
| Payout 3Y | 9.44 % |
When does Hikma Pharmaceuticals pay a dividend?
| Year | Dividend | Ex-day & Payday |
Frequency | |
|---|---|---|---|---|
| Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
| 2026 |
£0.2909
£0.29
|
Aug 13 2026
Aug 13 2026
Sep 17 2026
Aug 13 26
Sep 17 26 |
Sep 17 2026 |
-
-
|
| 2026 |
£0.35292
£0.35
|
Mar 19 2026
Mar 19 2026
Apr 30 2026
Mar 19 26
Apr 30 26 |
Apr 30 2026 |
-
-
|
| 2025 |
£0.27243
£0.27
|
Aug 14 2025
Aug 14 2025
Sep 18 2025
Aug 14 25
Sep 18 25 |
Sep 18 2025 |
-
-
|
| 2025 |
£0.37209
£0.37
|
Mar 20 2025
Mar 20 2025
May 01 2025
Mar 20 25
May 01 25 |
May 01 2025 |
-
-
|
| 2024 |
£0.24265
£0.24
|
Aug 15 2024
Aug 15 2024
Sep 20 2024
Aug 15 24
Sep 20 24 |
Sep 20 2024 |
-
-
|
| 2024 |
£0.37143
£0.37
|
Mar 21 2024
Mar 21 2024
May 03 2024
Mar 21 24
May 03 24 |
May 03 2024 |
-
-
|
| 2023 |
£0.19882
£0.2
|
Aug 10 2023
Aug 10 2023
Sep 15 2023
Aug 10 23
Sep 15 23 |
Sep 15 2023 |
-
-
|
| 2023 |
£0.29524
£0.3
|
Mar 23 2023
Mar 23 2023
May 05 2023
Mar 23 23
May 05 23 |
May 05 2023 |
-
-
|
| 2022 |
£0.16
£0.16
|
Aug 18 2022
Aug 18 2022
Sep 20 2022
Aug 18 22
Sep 20 22 |
Sep 20 2022 |
-
-
|
| 2022 |
£0.26
£0.26
|
Mar 17 2022
Mar 17 2022
Apr 28 2022
Mar 17 22
Apr 28 22 |
Apr 28 2022 |
-
-
|
How much dividend does Hikma Pharmaceuticals pay?
Hikma Pharmaceuticals most recently paid a dividend of £0.29. Hikma Pharmaceuticals paid a Dividend of £0.64 Per Share in the financial year 2025. With a stock price of £16.25 at Sep 24 2026, the current dividend yield is 3.97% (calculation: £0.64 / £16.25 = 3.97%). No special dividend was paid.
What is the Hikma Pharmaceuticals Dividend Yield and payout ratio?
The average Hikma Pharmaceuticals dividend yield over the last 5 years is 2.93% and the average over the last 10 years is 2.47%.
The payout ratio of Hikma Pharmaceuticals in relation to the last financial year is 39.06%. The payout ratio smoothed over 3 years is 49.93%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
| Metric | Hikma Pharmaceuticals |
|---|---|
| Current dividend yield | 3.97% |
| Dividend Yield 5Y | 2.93% |
| Dividend Yield 10Y | 2.47% |
| Payout 1Y | 39.06% |
| Payout 3Y | 49.93% |
Is the Hikma Pharmaceuticals dividend safe? Continuity & Dividend Growth
Is the Hikma Pharmaceuticals dividend safe?
Hikma Pharmaceuticals has been paying a dividend for 20 years and has not lowered the dividend for 20 years (dividend continuity). As a result, the dividend was recently increased 20-times.
The Dividend Growth in relation to the previous financial year amounts to 4.96%. The average Hikma Pharmaceuticals Dividend Growth over the last 5 years is 12.22%. The average for the last 10 years is 12.17%.
| Metric | Hikma Pharmaceuticals |
|---|---|
| Increased | 20 Years |
| Continuity | 20 Years |
| Paid | 20 Years |
| Growth 1Y | 4.96% |
| Growth 5Y | 12.22% |
| Growth 10Y | 12.17% |
Continuity
Hikma Pharmaceuticals has been paying a dividend for 20 years and has not lowered the dividend for 20 years (dividend continuity). As a result, the dividend was recently increased 20-times.
Dividend Growth
The Dividend Growth in relation to the previous financial year amounts to 4.96%. The average Hikma Pharmaceuticals Dividend Growth over the last 5 years is 12.22%. The average for the last 10 years is 12.17%.
Hikma Pharmaceuticals Stock Forecast 2026
On the stock exchange, the Hikma Pharmaceuticals stock (ISIN: GB00B0LCW083) is traded at September 2026 as a Top Scorer according to the dividend strategy.
The stock price of Hikma Pharmaceuticals 7.31% has risen since the beginning of the year 2026. However, the return generated in the past says nothing about the future return. You can find the Hikma Pharmaceuticals stock price in real time at the top of the page.
Hikma Pharmaceuticals (symbol: HIK) is valued at a Price / Earnings Ratio (P/E ratio) of 10.09 and a price/sales ratio (P/S ratio) of 1.28 valued. Based on analyst estimates, the Hikma Pharmaceuticals stock forecast 2026 of the current financial year corresponds to a valuation of 9.11 according to P/E ratio and 1.22 according to P/S.
| Metric | Hikma Pharmaceuticals |
|---|---|
| Dividend Score | ??/15 |
| Performance 2026 |
7.31%
|
| P/E TTM | 10.09 |
| P/S TTM | 1.28 |
| P/E forward | 9.11 |
| P/S forward | 1.22 |
Hikma Pharmaceuticals (symbol: HIK) is valued at a Price / Earnings Ratio (P/E ratio) of 10.09 and a price/sales ratio (P/S ratio) of 1.28 valued. Based on analyst estimates, the Hikma Pharmaceuticals stock forecast 2026 of the current financial year corresponds to a valuation of 9.11 according to P/E ratio and 1.22 according to P/S.
Discover more Dividend Stocks in Germany, USA and Worldwide
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
